Cargando...
NasdaqGS: INCY
Métricas de valuación y rentabilidad de la empresa frente a sus pares de industria. La empresa analizada aparece destacada en la primera fila.
| Empresa | Market Cap | P/E | EV/EBITDA | P/S | ROE | Margen Op. |
|---|---|---|---|---|---|---|
INCY Incyte CorporationEsta empresa | $21,7B | N/A | 10,04x | 3,67x | 30,82% | 25,55% |
VRTX Vertex Pharmaceuticals Incorpor | $112,9B | N/A | 20,60x | 8,85x | 24,20% | 38,13% |
REGN Regeneron Pharmaceuticals, Inc. | $64,2B | N/A | 15,08x | 5,01x | 14,55% | 20,66% |
MRNA Moderna, Inc. | $19,8B | N/A | -6,68x | 9,55x | -36,56% | -131,10% |
TECH Bio-Techne Corp | $8,5B | N/A | 21,77x | 6,27x | 5,34% | 24,61% |